Rani Therapeutics Holdings (RANI) Interest & Investment Income (2020 - 2026)
Rani Therapeutics Holdings' (RANI) quarterly Interest & Investment Income came in at $412000.0 in Q1 2026, up 88.99% year-on-year from $218000.0 in Q1 2025, and up 7.29% quarter-over-quarter from $384000.0 in Q4 2025.
Rani Therapeutics Holdings (RANI) Interest & Investment Income (2020 - 2026) Analysis & Trends
Rani Therapeutics Holdings' Interest & Investment Income history runs 7 years deep, the most recent figure standing at $412000.0 for Q1 2026.
- On a quarterly basis, Interest & Investment Income rose 88.99% year-over-year to $412000.0 in Q1 2026; TTM through Mar 2026 was $1.0 million, a 28.58% decrease from a year earlier, with the FY2025 full-year figure at $827000.0, down 53.09% from the prior year.
- Interest & Investment Income rose to $412000.0 in Q1 2026 per RANI's latest filing, from $384000.0 in the prior quarter.
- Across five years, Interest & Investment Income topped out at $896000.0 in Q2 2023 and bottomed at $15000.0 in Q1 2022.
- The 5-year median for Interest & Investment Income is $412000.0 (2026), against an average of $444117.6.
- Across the five-year window, Interest & Investment Income soared 5840.0% in 2023 and slumped 83.57% in 2025, its largest moves.
- Year by year, Interest & Investment Income stood at $818000.0 in 2022, then declined by 17.48% to $675000.0 in 2023, then slumped by 46.67% to $360000.0 in 2024, then climbed by 6.67% to $384000.0 in 2025, then rose by 7.29% to $412000.0 in 2026.
- Per Business Quant, the three latest RANI Interest & Investment Income figures stand at $412000.0 (Q1 2026), $384000.0 (Q4 2025), and $68000.0 (Q3 2025).
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Int & Inv Inc (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,621.14 Bn | 66,620.85 Bn | - | - |
| 2 | Nanobiotix | 1,915.18 Bn | 1,915.11 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | - |
| 4 | BeOne Medicines | 471.27 Bn | 466.48 Bn | 1.35 Bn | 27.66 Mn |
| 5 | Vertex Pharmaceuticals | 121.81 Bn | 114.57 Bn | 2.59 Bn | 114.80 Mn |
| 6 | Regeneron Pharmaceuticals | 69.58 Bn | 60.82 Bn | 3.31 Bn | -65.80 Mn |
| 7 | Belite Bio | 62.72 Bn | 62.72 Bn | - | - |
| 8 | Argenx Se | 55.51 Bn | 50.33 Bn | 1.41 Bn | 48.00 Mn |
| 9 | Revolution Medicines | 37.35 Bn | 37.35 Bn | - | 19.51 Mn |
| 10 | Rani Therapeutics Holdings | 144.81 Mn | 144.81 Mn | - | 412,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 412,000.00 |
| Dec 31, 2025 | 384,000.00 |
| Sep 30, 2025 | 68,000.00 |
| Jun 30, 2025 | 158,000.00 |
| Mar 31, 2025 | 218,000.00 |
| Dec 31, 2024 | 360,000.00 |
| Sep 30, 2024 | 414,000.00 |
| Jun 30, 2024 | 439,000.00 |
| Mar 31, 2024 | 549,000.00 |
| Dec 31, 2023 | 675,000.00 |
| Sep 30, 2023 | 839,000.00 |
| Jun 30, 2023 | 896,000.00 |
| Mar 31, 2023 | 891,000.00 |
| Dec 31, 2022 | 818,000.00 |
| Sep 30, 2022 | 379,000.00 |
| Jun 30, 2022 | 35,000.00 |
| Mar 31, 2022 | 15,000.00 |
| Dec 31, 2021 | 16,000.00 |
| Sep 30, 2021 | 13,000.00 |
| Jun 30, 2021 | 13,000.00 |